An FDA Panel Just Endorsed These Unproven Peptides
Peptides are inching closer to the mainstream. A panel of experts on Thursday narrowly recommended that the Food…
Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
(Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
(Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
(Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills
(Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
FDA is urged by advocacy group to ban DTC prescription drug ads
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Market for psychedelic drugs to treat mental health gets a buy signal
Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement…
Unresolved Cyclospora Parasite Outbreak Raises Questions About CDC Cuts
The CDC has experienced several budget cuts under the Trump administration, which may have affected it’s ability to…
Maharashtra FDA Acts Against Cadila Pharma; Bars Sale Of Two Sets Of Medicines Over Brand Confusion
The Maharashtra Food and Drug Administration has barred the sale and distribution of some medicines manufactured by Cadila…
2 marketing tricks that make supplements seem safer than they are
Stroll down the supplement aisle and you’ll find no shortage of labels, badges and buzzwords meant to put…
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Compass Pathways Clears Another Hurdle – Builds Stronger FDA Case For Its Much-Awaited Depression Therapy
Among patients receiving a 25 mg dose, 39% achieved a clinically meaningful reduction in depression symptoms by Week…